CTLA4 and neoplasm: To examine the influence of immunotherapy on tumour growth and clonal dynamics, we compared WT mice treated with immunotherapy (anti-PD1 + anti-CTLA4) or control antibodies starting from day 10 when tumours were ~200 mm3 (Fig. 2A).